Systemic Treatment for Unresectable Hepatocellular Carcinoma: A Surgeon's Perspective.

J Hepatocell Carcinoma · 2025 · PMC11873029 · PMID 40034975

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the interim analysis, OS, a co-primary end point of this study, showed a trend toward improvement (HR=0.80, 95% CI, 0.57–1.11).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.